[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2011/92698,2011,A1Locationinpatent:Page/Pagecolumn26-27
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2011/92698,2011,A1Locationinpatent:Page/Pagecolumn27
1260876-51-4
1308384-31-7
1311391-25-9
157634-00-9
203503-03-1
207405-59-2
1219795-04-6 | 4-n-Butylphenol--d4,OD | AA009XKC
1256824-49-3 | 6-Bromo-4-methylpyridin-3-ol | AA009YAS | MFCD18255424
133427-95-9 | 2-(4-FLUOROPHENYL)IMIDAZO[1,2-A]PYRIDINE-8-CARBOXYLIC ACID | AA009YL8 | MFCD05256204
1329837-75-3 | rac AMbrisentan-d3 Methyl Ester | AA009Z04
1228560-89-1 | (S)-2-(4-Chlorophenyl)pyrrolidine hydrochloride | AA009ZL7 | MFCD08751466
1357946-34-9 | 3,6-Dibromo-1H-pyrazolo[4,3-c]pyridine | AA00A00C | MFCD22380429
129027-65-2 | 1-(tert-Butyl)-1H-1,2,3-triazole-4-carbaldehyde | AA00A0H1 | MFCD18250433
1359986-20-1 | 1,2-Dibromo-4-methoxy-3,5,6-trimethylbenzene | AA00A0ZA | MFCD22370201
1416561-90-4 | O-Propargyl-PuroMycin | AA00A1DQ | MFCD28386284
1228070-89-0 | 4-Amino-n-(2-aminoethyl)-1,2,5-oxadiazole-3-carboxamide | AA00A2ON | MFCD00823190